BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17234759)

  • 1. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
    Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
    Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin.
    Kim H; Lim JY; Kim YH; Kim H; Park SH; Lee KH; Han H; Jeun SS; Lee JH; Rha HK
    Mol Cells; 2002 Aug; 14(1):108-14. PubMed ID: 12243339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein.
    Lim JY; Kim H; Jeun SS; Kang SG; Lee KJ
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1151-7. PubMed ID: 16405865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
    Chen KC; Zhou Y; Zhang W; Lou MF
    Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Son of sevenless by the membrane-actin linker protein ezrin.
    Geissler KJ; Jung MJ; Riecken LB; Sperka T; Cui Y; Schacke S; Merkel U; Markwart R; Rubio I; Than ME; Breithaupt C; Peuker S; Seifert R; Kaupp UB; Herrlich P; Morrison H
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20587-92. PubMed ID: 24297905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
    Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin.
    Muranen T; Grönholm M; Renkema GH; Carpén O
    Oncogene; 2005 Feb; 24(7):1150-8. PubMed ID: 15580288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
    Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
    Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPS8 and E3B1 transduce signals from Ras to Rac.
    Scita G; Nordstrom J; Carbone R; Tenca P; Giardina G; Gutkind S; Bjarnegård M; Betsholtz C; Di Fiore PP
    Nature; 1999 Sep; 401(6750):290-3. PubMed ID: 10499589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI; Haipek CA; Gutmann DH
    Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism.
    Lambert JM; Lambert QT; Reuther GW; Malliri A; Siderovski DP; Sondek J; Collard JG; Der CJ
    Nat Cell Biol; 2002 Aug; 4(8):621-5. PubMed ID: 12134164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
    Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
    Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding light on Merlin's wizardry.
    Okada T; You L; Giancotti FG
    Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAP, a protein interacting with a tumor suppressor, merlin, through the run domain.
    Lee IK; Kim KS; Kim H; Lee JY; Ryu CH; Chun HJ; Lee KU; Lim Y; Kim YH; Huh PW; Lee KH; Han SI; Jun TY; Rha HK
    Biochem Biophys Res Commun; 2004 Dec; 325(3):774-83. PubMed ID: 15541357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenite blocks growth factor induced activation of the MAP kinase cascade, upstream of Ras and downstream of Grb2-Sos.
    Doza YN; Hall-Jackson CA; Cohen P
    Oncogene; 1998 Jul; 17(1):19-24. PubMed ID: 9671310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Horiguchi A; Zheng R; Shen R; Nanus DM
    Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
    Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
    Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.
    Ryu CH; Kim SW; Lee KH; Lee JY; Kim H; Lee WK; Choi BH; Lim Y; Kim YH; Lee KH; Hwang TK; Jun TY; Rha HK
    Oncogene; 2005 Aug; 24(34):5355-64. PubMed ID: 16007223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.